Baron & Budd Helps Secure Key Ninth Circuit Ruling Expanding FCA to Drug Discount Program
Baron & Budd played a central role in a significant unanimous decision by the Ninth Circuit Court, which reversed a district court ruling and allowed [...]
Andrew Miller Recognized in Legal 500 2026 Washington DC White Collar Crime Guide
DALLAS – Today, the nationally recognized law firm Baron & Budd is pleased to announce that Shareholder Andrew Miller has been ranked in the 2026 [...]
DOJ’s Antitrust Division Issues First Ever Whistleblower Reward for $1 Million
Recently, the U.S. Department of Justice’s Antitrust Division announced that EBLOCK Corporation agreed to pay a $3.28 million criminal fine to resolve criminal antitrust and [...]
Andrew Miller Featured on Trade Podcast to Talk Customs Fraud, Whistleblowers, and More
Baron & Budd Shareholder Andrew Miller was featured on the podcast Torres Talks Trade for a two-part interview on Trade, Tariffs, and Whistleblowers, hosted by [...]
Federal Government Steps Up Trade Fraud Enforcement Efforts with Task Force
The Department of Justice along with the Department of Homeland Security have launched a cross-agency Trade Fraud Task Force to ramp up enforcement against importers [...]
Raytheon and Nightwing Group Agree to Pay $8.4 Million for Cybersecurity Compliance Fraud
Last month, the aerospace and defense giant Raytheon Company (now part of RTX Corporation) and its successor Nightwing Group LLC agreed to pay $8.4 million [...]
With Tariffs Ramping Up, Possibility of Customs Duty Fraud Heightens
Recently, the federal government has implemented a raft of tariffs on imports from dozens of countries, including China. Since then, those governments have responded with [...]
Baron & Budd Obtains Record Settlement in Restaurant Revitalization Fraud Lawsuit Against CoreLife Eatery, LLC
A whistleblower, represented by Baron & Budd, came forward with information about the fraudulently obtained grant money. Washington, D.C. – Today, the national law firm [...]
DOJ Files Complaint in Intervention in Baron & Budd Whistleblower Lawsuit Against Walgreens
Walgreens allegedly failed in its duties under the Controlled Substances Act by filling medically unnecessary prescriptions and ignoring red flags. Washington, D.C. -- Yesterday, the [...]
